<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Bionomics Ltd.</title><link>https://investorshangout.com/Bionomics-Ltd-BNOEF-90870/</link><description><![CDATA[Bionomics Ltd. (BNOEF)]]></description><language>en-us</language><pubDate>Mon, 19 Oct 2026 05:54:30 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/Bionomics-Ltd-BNOEF-90870/" rel="self" type="application/rss+xml"/><item><title>whytestocks: $BNOEF News Article - Bionomics Limited Announces Pricing of Initial Public Offering in the United S</title><link>https://investorshangout.com/post/view?id=6303052</link><guid>https://investorshangout.com/post/view?id=6303052</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 16 Dec 2021 15:20:48 GMT</pubDate></item><item><title>whytestocks: $BNOEF News Article - Bionomics BNC210 Expansion into Social Anxiety Disorder </title><link>https://investorshangout.com/post/view?id=6130988</link><guid>https://investorshangout.com/post/view?id=6130988</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 10 May 2021 20:25:49 GMT</pubDate></item><item><title>whytestocks: $BNOEF News Article - Positive BNC210 7-Day Dosing Pharmacokinetic Study Exceeds Blood Exposure Proj</title><link>https://investorshangout.com/post/view?id=6061262</link><guid>https://investorshangout.com/post/view?id=6061262</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 22 Feb 2021 13:15:47 GMT</pubDate></item><item><title>whytestocks: $BNOEF News Article - Joint feasibility assessment of Bionomics&#039; BNC210 and EmpathBio&#039;s MDMA derivat</title><link>https://investorshangout.com/post/view?id=6056534</link><guid>https://investorshangout.com/post/view?id=6056534</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 17 Feb 2021 15:35:46 GMT</pubDate></item></channel></rss>